The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

Tomas Breidahl Department of Experimental Clinical Oncology, Aarhus University Hospital, DK-8000, Aarhus C, Denmark; MR Research Centre, Aarhus University, Skejby Hospital, Aarhus N, Denmark

Flemming U. Nielsen MR Research Centre, Aarhus University, Skejby Hospital, Aarhus N, Denmark; MRI Department, Bioindustry Park Canavese, Colleretto Giacosa, Italy

Hans Stødkilde-Jørgensen MR Research Centre, Aarhus University, Skejby Hospital, Aarhus N, Denmark

Ross J. Maxwell MR Research Centre, Aarhus University, Skejby Hospital, Aarhus N, Denmark; Gray Cancer Institute, Mount Vernon Hospital, Northwood, Middlesex, UK

Michael R. Horsman Department of Experimental Clinical Oncology, Aarhus University Hospital, DK-8000, Aarhus C, DenmarkCorrespondence[email protected]

The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date